Table 2. Gene expression stability.
| miRNA | MC < 1.5 | Serum | Plasma | ||
|---|---|---|---|---|---|
| Average count | SD | Average count | SD | ||
| hsa-miR-95-3p | 0.731 | 1.3 | 0.052 | 3.221 | 0.857 |
| hsa-miR-92b-3p | 0.736 | 1.286 | 0.052 | 1.321 | 0.195 |
| hsa-miR-576-5p | 0.737 | 1.286 | 0.052 | 2.041 | 0.503 |
| hsa-miR-511-5p | 0.74 | 1.286 | 0.052 | 1.406 | 0.154 |
| hsa-miR-608 | 0.744 | 1.286 | 0.052 | 1.225 | 0.09 |
| hsa-miR-876-3p | 0.75 | 1.286 | 0.052 | 2.002 | 0.452 |
| hsa-miR-579-5p | 0.75 | 1.286 | 0.052 | 1.132 | 0.027 |
| hsa-miR-337-3p | 0.754 | 2.925 | 0.758 | 17.445 | 2.625 |
| hsa-miR-363-5p | 0.755 | 1.286 | 0.052 | 1.196 | 0.047 |
| hsa-miR-378f | 0.755 | 1.653 | 0.192 | 13.554 | 2.866 |
Gene expression stability was performed using geNorm to derive geometric means using raw miRNA counts from all serum and plasma samples. The gene-stability measure M is the average pairwise variation between this miRNA gene and all other genes. An increasing ratio variation corresponds to decreasing expression stability of the tested gene. The top ten most highly stable miRNA with least variation on expression in all samples are shown, along with corresponding average counts and SD in serum and plasma.